FREE Account Opening + No Clearing Fees

Command Polymers BSE SME IPO review (Avoid)

Review By Dilip Davda on March 15, 2023

•    CPL is in the business of manufacturing and trading polymer-based products. 
•    So far it has reported an average financial performance. 
•    On the bases of annualized FY23 earnings, the issue is priced exorbitantly. 
•    The company is operating in a highly competitive and fragmented segment. 
•    There is no harm in skipping this pricey issue. 

Command Polymers Ltd. (CPL) is engaged in the business of Marketing and Manufacturing Polymer-based products primarily Polythene LF tubes, Tarpaulin sheets, Polyester Fabrics and other polymers. CPL's products have a wide variety of applications in several industries such as Industrial packaging industries, the Food industry etc. It generates 67% of its revenue from manufacturing activities and the rest from trading in related materials. 

As of December 31, 2022, it had 14 employees on its payroll. It also employs part-time local labourers as and when needed. 

The company is coming out with a maiden IPO of 2532000 equity shares of Rs. 10 each at a fixed price of Rs. 28 per share to mobilize Rs. 7.09 cr. The issue opens for subscription on March 17, 2023, and will close on March 21, 2023. The minimum application to be made is for 4000 shares and in multiples thereon, thereafter. Post allotment, shares will be listed on BSE SME. The issue constitutes 27% of the post-issue paid-up capital of the company. CPL is spending Rs. 0.52 cr. for this IPO process and from the net proceedings, it will utilize Rs. 4.13 cr. for working capital and Rs. 1.80 cr. for repayment of loans, and Rs. 0.64 cr. for general corporate purposes.  

Aryaman Financial Services Ltd. is the sole lead manager and KFin Technologies Ltd. is the registrar of the issue. Aryaman group company Aryaman Capital Markets Ltd. is the market maker for the company. 

Having issued most of its equity shares at par, the company also raised further equity at a price of Rs. 100 per share in February 2009. The average cost of the acquisition of shares by the promoters is Rs. 13.50 per share. 

Post-IPO, CPL's current paid-up equity capital of Rs. 6.85 cr. will stand enhanced to Rs.9.38 cr. Based on the IPO pricing, the company is looking for a market cap of Rs. 26.26 cr.

On the financial performance front, for the last three fiscals, CPL has posted a turnover/net profit of Rs. 10.90 cr. / Rs. 0.09 cr. (FY20), Rs. 16.37 cr. / Rs. 0.20 cr. (FY21), and Rs. 19.49 cr. / Rs. 0.30 cr. (FY22). For 3Qs of FY23 ended on December 31, 2022, it earned a net profit of Rs. 0.16 cr. on a turnover of Rs. 14.60 cr. 

Its EBITDA margins have declined from 14.66% as of March 31, 2020, to 6.48% as of December 31, 2022, and RoCE has declined from 3.93% to 0.06% for the said periods. Its net debt to EBITDA ratio is at 6.48 as of December 31, 2022, which raises major concerns. 

For the last three fiscals, CPL has reported an average EPS of Rs. 0.34 and an average RoNW of 2.43%. The issue is priced at a P/BV of 1.96 based on its NAV of Rs. 14.30 as of December 31, 2022, and at a P/BV of 1.56 based on its post-IPO NAV of Rs. 18.00 per share. 

If we annualize FY23 earnings and attribute it to post-IPO fully diluted paid-up equity capital, then the asking price is at a P/E of 121.74. Thus the issue is exorbitantly priced. 

The company has not declared any dividends for the reported periods of the offer document. It will adopt a prudent dividend policy post-listing, based on its financial performance and future prospects. 

As per the offer document, the company has shown G M Polyplast as their listed peers. It is quoting at a P/E of NA (as of March 15, 2023). However, they are not truly comparable on an apple-to-apple basis.  

This is the 17th mandate from Aryaman Financial in the last three fiscals (including the ongoing one). Out of the last 10 listings, 2 opened at par and the rest were listed at premiums ranging from 0.02% to 27.18% on the listing date. 

Conclusion / Investment Strategy

The company is operating in a highly competitive and fragmented segment. It has posted an average financial performance so far. Based on its FY23 annualized earnings, the issue is priced exorbitantly. There is no harm in skipping this pricey bet.

Reviewer recommends Avoid to the issue.

Review By Dilip Davda on March 15, 2023

Review Author

DISCLAIMER: No financial information whatsoever published anywhere here should be construed as an offer to buy or sell securities, or as advice to do so in any way whatsoever. All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions. My reviews do not cover GMP market and operators game plans. Readers must consult a qualified financial advisor before making any actual investment decisions, based the on information published here. With entry barriers, SEBI wants only well-informed investors to participate in such offers. With crazy listings in the recent past, SME IPOs drew the attention of investors across the board and lead to seer madness. However, as SME issues have entry barriers and continued low preference from the broking community, any reader taking decisions based on any information published here does so entirely at their own risk. The above information is based on information available as of date coupled with market perceptions. The Author has no plans to invest in this offer.

About Dilip Davda

Dilip Davda

Dilip Davda is veteran journalist associated with stock market since 1978. He is contributing to print and electronic media on stock markets/insurance/finance since 1985.

Dilip Davda is a leading reviewer of public issues and NCDs in the primary stock market in India. The knowledge he gained over 3 decades while working in the stock market and a strong relationship with popular lead managers makes his reviews unique. His detail fundamental and financial analysis of companies coming up with IPO helps investors in the primary stock market. Dilip Davda has a special interest in analyzing the SME companies and writing reviews about their public issues. His reviews are regularly published online and in news papers.

(Dilip Davda -SEBI registered Research Analyst-Mumbai,

Registration no. INH000003127 (Perpetual)

Email id: ).

Command Polymers IPO FAQs

  1. 1. Why Command Polymers IPO?

    The initial public offer (IPO) of Command Polymers Limited offers an early investment opportunity in Command Polymers Limited. A stock market investor can buy Command Polymers IPO shares by applying in IPO before Command Polymers Limited shares get listed at the stock exchanges. An investor could invest in Command Polymers IPO for short term listing gain or a long term.

  2. 2. How is Command Polymers IPO?

    Read the Command Polymers IPO recommendations by the leading analyst and leading stock brokers.

  3. 3. Command Polymers IPO what should investors do?

    Command Polymers IPO offers an opportunity to buy IPO shares before they get listed at the stock exchanges. Read the Command Polymers IPO Notes, Analysis and Recommendations by leading stock brokerage firms and experts in the above answer.

  4. 4. Is Command Polymers IPO good?

    Our recommendation for Command Polymers IPO is to avoid.

  5. 5. Is Command Polymers IPO worth Investing?

    As per the analysis by our lead analyst Mr. Dilip Davda, we suggest you to avoid the Command Polymers IPO.

  6. 6. When will Command Polymers IPO allotment status?

    The Command Polymers IPO allotment status will be available on or around March 24, 2023. The allotted shares will be credited in demat account by March 28, 2023. Visit Command Polymers IPO allotment status to check.

  7. 7. When will Command Polymers IPO list?

    The Command Polymers IPO will list on Wednesday, March 29, 2023, at BSE SME.